Thyroxine (T4)/3,5,3′-Triiodo-L-Thyronine (T3) Ratio Affects the Metabolism of Anti-Colorectal Cancer Drug Irinotecan

被引：0

作者：

Kang, Xian-Wu ^{[1
]}

Kong, Bin ^{[1
]}

Chen, Qiang ^{[1
]}

Wang, Zhuo ^{[1
]}

Zhao, Shi-Peng ^{[1
]}

机构：

[1] Hebei Med Univ, Hosp 3, Dept Anorectal Surg, 139 Ziqiang Rd, Shijiazhuang, Hebei, Peoples R China

来源：

LATIN AMERICAN JOURNAL OF PHARMACY | 2016年 / 35卷 / 09期

关键词：

colon cancer; glucuronidation; irinotecan; thyroxine (T4); 3,5,3 '-triiodo-L-thyronine (T3); UDP-GLUCURONOSYLTRANSFERASE UGT; MODEL; TOXICITY; THERAPY; ACIDS;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Colon cancer remains to threaten the health of humans, and irinotecan is the first-line drug to treat colon cancer. The in vivo metabolism of irinotecan-contains carboxylesterases (CES)-catalyzed hydrolysis reaction to form SN-38 and UDP-glucuronosyltransferase (UGT) 1A1-catalyzed glucuronidation of SN-38. The present study aims to investigate the inhibition of two important endogenous substances thyroxine (T4) and 3,5,3'-triiodo-L-thyronine (T3) on the glucuronidation of SN-38. A 235% of activity was inhibited by 100 mu M of T3, and 962% activity was inhibited by 100 uM of T4. To understand the inhibition mechanism, the inhibition of T4 on the activity of UGT1A1 was determined, and 100 mu M of T4 completely inhibited the activity of UGT1A1. In conclusion, thyroxine (T4)/3,5,3'-triiodo-L-thyronine (T3) ratio affects the metabolism of anti-colorectal cancer drug irinotecan.

引用

页码：2113 / 2116

页数：4

共 50 条

[31] 3,5,3'-triiodo-L-thyronine and L-thyroxine uptake into red blood cells of rainbow trout, Oncorhynchus mykiss
McLeese, JM
Eales, JG
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1996, 102 (01) : 47 - 55
[32] DIRECT EFFECTS OF ACUTE ADMINISTRATION OF 3,5,3'-TRIIODO-L-THYRONINE ON MYOCYTE FUNCTION
WALKER, JD
CRAWFORD, FA
MUKHERJEE, R
ZILE, MR
SPINALE, FG
ANNALS OF THORACIC SURGERY, 1994, 58 (03): : 851 - 856
[33] Sensitive LC-MS/MS method: T3 (3,3,5′-Triiodo-L-Thyronine) and (T4) Thyroxine determination in rat serum - Plain vs. clot activator collection tubes
Diaram, Sunetha
TOXICOLOGY LETTERS, 2017, 280 : S300 - S300
[34] COMPOSITION OF NONEXTRACTABLE RADIOACTIVITY FORMED AFTER INJECTION OF LABELED L-THYROXINE AND 3,5,3'-TRIIODO-L-THYRONINE IN RATS
SURKS, MI
OPPENHEIMER, JH
ENDOCRINOLOGY, 1970, 87 (03) : 567 - +
[35] L-THYROXINE AND 3,5,3'-TRIIODO-L-THYRONINE IN RAT EMBRYOS BEFORE ONSET OF FETAL THYROID-FUNCTION
OBREGON, MJ
MALLOL, J
PASTOR, R
DEESCOBAR, GM
DELREY, FE
ENDOCRINOLOGY, 1984, 114 (01) : 305 - 307
[36] Nongenomic actions of L-thyroxine and 3,5,3′-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase"
Bhargava, Maneesh
Lei, Jianxun
Ingbar, David H.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (05): : C977 - C979
[37] EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) AND 3,5-DIMETHYL-3'-ISOPROPYL-L-THYRONINE (DIMIT) ON CEREBRAL MITOCHONDRIA AND MECHANISM OF THEIR PASSAGE ACROSS THE HEMATOENCEPHALIC BOUNDARY IN THE HYPOTHYROID RAT
CLOT, JP
DEMBRI, A
MICHEL, O
MICHEL, R
ANNALES D ENDOCRINOLOGIE, 1985, 46 (03) : 171 - 171
[38] INTRACELLULAR-TRANSPORT OF 3,5,3'-TRIIODO-L-THYRONINE IN RAT SKELETAL MYOBLASTS
PONTECORVI, A
LAKSHMANAN, M
ROBBINS, J
ENDOCRINOLOGY, 1987, 121 (06) : 2145 - 2152
[39] Ion-trap mass spectrometry for determination of 3,5,3′-triiodo-L-thyronine and 3,5,3′,5′-tetraiodo-L-thyronine in neonatal rat cardiomyocytes
Vacek, Jan
Kosina, Pavel
Gabrielova, Eva
Modriansky, Martin
Ulrichova, Jitka
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 53 (03) : 688 - 692
[40] DETERMINATION OF 3,5,3'-TRIIODO-L-THYRONINE (T3) LEVELS IN TISSUES OF RAINBOW-TROUT (SALMO-GAIRDNERI) AND THE EFFECT OF LOW AMBIENT PH AND ALUMINUM
FOK, P
EALES, JG
BROWN, SB
FISH PHYSIOLOGY AND BIOCHEMISTRY, 1990, 8 (04) : 281 - 290

← 1 2 3 4 5 →